Impact of COVID-19 Outbreak on Vigabatrin, Global Market Research Report 2020
This report also analyses the impact of Coronavirus COVID-19 on the Vigabatrin industry.
Based on our recent survey, we have several different scenarios about the Vigabatrin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Vigabatrin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Vigabatrin market is segmented into
The Vigabatrin market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vigabatrin market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Vigabatrin market include:
Based on our recent survey, we have several different scenarios about the Vigabatrin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Vigabatrin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Vigabatrin market is segmented into
- Tablet
- Powder
- Infantile Spasms (IS)
- Partial-Onset Seizures
- Refractory Complex Partial Seizures
The Vigabatrin market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vigabatrin market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Vigabatrin market include:
- Sanofi
- Benta Pharma Industries
- Dr. Fisher Farma
- Lundbeck
- Novartis
- Perrigo
- Grindeks
- Endo International
- Amneal Pharma
- Cipla
- Upsher-Smith
1 VIGABATRIN MARKET OVERVIEW
1.1 Product Overview and Scope of Vigabatrin
1.2 Covid-19 Implications on Vigabatrin Segment by Type
1.2.1 Global Vigabatrin Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tablet
1.2.3 Powder
1.3 Covid-19 Implications on Vigabatrin Segment by Application
1.3.1 Vigabatrin Sales Comparison by Application: 2020 VS 2026
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Covid-19 Implications on Global Vigabatrin Market Size Estimates and Forecasts
1.4.1 Global Vigabatrin Revenue 2015-2026
1.4.2 Global Vigabatrin Sales 2015-2026
1.4.3 Vigabatrin Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Vigabatrin Industry Impact
1.5.1 How the Covid-19 is Affecting the Vigabatrin Industry
1.5.1.1 Vigabatrin Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Vigabatrin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Vigabatrin Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL VIGABATRIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Vigabatrin Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vigabatrin Revenue Share by Manufacturers (2015-2020)
2.3 Global Vigabatrin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vigabatrin Manufacturing Sites, Area Served, Product Type
2.5 Vigabatrin Market Competitive Situation and Trends
2.5.1 Vigabatrin Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vigabatrin Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON VIGABATRIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Vigabatrin Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vigabatrin Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vigabatrin Market Facts & Figures by Country
3.3.1 North America Vigabatrin Sales by Country
3.3.2 North America Vigabatrin Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vigabatrin Market Facts & Figures by Country
3.4.1 Europe Vigabatrin Sales by Country
3.4.2 Europe Vigabatrin Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vigabatrin Market Facts & Figures by Region
3.5.1 Asia Pacific Vigabatrin Sales by Region
3.5.2 Asia Pacific Vigabatrin Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vigabatrin Market Facts & Figures by Country
3.6.1 Latin America Vigabatrin Sales by Country
3.6.2 Latin America Vigabatrin Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vigabatrin Market Facts & Figures by Country
3.7.1 Middle East and Africa Vigabatrin Sales by Country
3.7.2 Middle East and Africa Vigabatrin Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL VIGABATRIN HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Vigabatrin Sales Market Share by Type (2015-2020)
4.2 Global Vigabatrin Revenue Market Share by Type (2015-2020)
4.3 Global Vigabatrin Price Market Share by Type (2015-2020)
4.4 Global Vigabatrin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL VIGABATRIN HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Vigabatrin Sales Market Share by Application (2015-2020)
5.2 Global Vigabatrin Revenue Market Share by Application (2015-2020)
5.3 Global Vigabatrin Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN VIGABATRIN BUSINESS
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 Benta Pharma Industries
6.2.1 Benta Pharma Industries Corporation Information
6.2.2 Benta Pharma Industries Description, Business Overview and Total Revenue
6.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Benta Pharma Industries Products Offered
6.2.5 Benta Pharma Industries Recent Development
6.3 Dr. Fisher Farma
6.3.1 Dr. Fisher Farma Corporation Information
6.3.2 Dr. Fisher Farma Description, Business Overview and Total Revenue
6.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dr. Fisher Farma Products Offered
6.3.5 Dr. Fisher Farma Recent Development
6.4 Lundbeck
6.4.1 Lundbeck Corporation Information
6.4.2 Lundbeck Description, Business Overview and Total Revenue
6.4.3 Lundbeck Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Lundbeck Products Offered
6.4.5 Lundbeck Recent Development
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description, Business Overview and Total Revenue
6.5.3 Novartis Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis Products Offered
6.5.5 Novartis Recent Development
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description, Business Overview and Total Revenue
6.6.3 Perrigo Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Perrigo Products Offered
6.6.5 Perrigo Recent Development
6.7 Grindeks
6.6.1 Grindeks Corporation Information
6.6.2 Grindeks Description, Business Overview and Total Revenue
6.6.3 Grindeks Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Grindeks Products Offered
6.7.5 Grindeks Recent Development
6.8 Endo International
6.8.1 Endo International Corporation Information
6.8.2 Endo International Description, Business Overview and Total Revenue
6.8.3 Endo International Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Endo International Products Offered
6.8.5 Endo International Recent Development
6.9 Amneal Pharma
6.9.1 Amneal Pharma Corporation Information
6.9.2 Amneal Pharma Description, Business Overview and Total Revenue
6.9.3 Amneal Pharma Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Amneal Pharma Products Offered
6.9.5 Amneal Pharma Recent Development
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description, Business Overview and Total Revenue
6.10.3 Cipla Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Cipla Products Offered
6.10.5 Cipla Recent Development
6.11 Upsher-Smith
6.11.1 Upsher-Smith Corporation Information
6.11.2 Upsher-Smith Vigabatrin Description, Business Overview and Total Revenue
6.11.3 Upsher-Smith Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Upsher-Smith Products Offered
6.11.5 Upsher-Smith Recent Development
7 VIGABATRIN MANUFACTURING COST ANALYSIS
7.1 Vigabatrin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vigabatrin
7.4 Vigabatrin Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Vigabatrin Distributors List
8.3 Vigabatrin Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Vigabatrin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vigabatrin by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vigabatrin by Type (2021-2026)
10.2 Vigabatrin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vigabatrin by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vigabatrin by Application (2021-2026)
10.3 Vigabatrin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vigabatrin by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vigabatrin by Region (2021-2026)
10.4 North America Vigabatrin Estimates and Projections (2021-2026)
10.5 Europe Vigabatrin Estimates and Projections (2021-2026)
10.6 Asia Pacific Vigabatrin Estimates and Projections (2021-2026)
10.7 Latin America Vigabatrin Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vigabatrin Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Vigabatrin
1.2 Covid-19 Implications on Vigabatrin Segment by Type
1.2.1 Global Vigabatrin Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tablet
1.2.3 Powder
1.3 Covid-19 Implications on Vigabatrin Segment by Application
1.3.1 Vigabatrin Sales Comparison by Application: 2020 VS 2026
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Covid-19 Implications on Global Vigabatrin Market Size Estimates and Forecasts
1.4.1 Global Vigabatrin Revenue 2015-2026
1.4.2 Global Vigabatrin Sales 2015-2026
1.4.3 Vigabatrin Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Vigabatrin Industry Impact
1.5.1 How the Covid-19 is Affecting the Vigabatrin Industry
1.5.1.1 Vigabatrin Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Vigabatrin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Vigabatrin Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL VIGABATRIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Vigabatrin Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vigabatrin Revenue Share by Manufacturers (2015-2020)
2.3 Global Vigabatrin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vigabatrin Manufacturing Sites, Area Served, Product Type
2.5 Vigabatrin Market Competitive Situation and Trends
2.5.1 Vigabatrin Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vigabatrin Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON VIGABATRIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Vigabatrin Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vigabatrin Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vigabatrin Market Facts & Figures by Country
3.3.1 North America Vigabatrin Sales by Country
3.3.2 North America Vigabatrin Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vigabatrin Market Facts & Figures by Country
3.4.1 Europe Vigabatrin Sales by Country
3.4.2 Europe Vigabatrin Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vigabatrin Market Facts & Figures by Region
3.5.1 Asia Pacific Vigabatrin Sales by Region
3.5.2 Asia Pacific Vigabatrin Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vigabatrin Market Facts & Figures by Country
3.6.1 Latin America Vigabatrin Sales by Country
3.6.2 Latin America Vigabatrin Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vigabatrin Market Facts & Figures by Country
3.7.1 Middle East and Africa Vigabatrin Sales by Country
3.7.2 Middle East and Africa Vigabatrin Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL VIGABATRIN HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Vigabatrin Sales Market Share by Type (2015-2020)
4.2 Global Vigabatrin Revenue Market Share by Type (2015-2020)
4.3 Global Vigabatrin Price Market Share by Type (2015-2020)
4.4 Global Vigabatrin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL VIGABATRIN HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Vigabatrin Sales Market Share by Application (2015-2020)
5.2 Global Vigabatrin Revenue Market Share by Application (2015-2020)
5.3 Global Vigabatrin Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN VIGABATRIN BUSINESS
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 Benta Pharma Industries
6.2.1 Benta Pharma Industries Corporation Information
6.2.2 Benta Pharma Industries Description, Business Overview and Total Revenue
6.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Benta Pharma Industries Products Offered
6.2.5 Benta Pharma Industries Recent Development
6.3 Dr. Fisher Farma
6.3.1 Dr. Fisher Farma Corporation Information
6.3.2 Dr. Fisher Farma Description, Business Overview and Total Revenue
6.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dr. Fisher Farma Products Offered
6.3.5 Dr. Fisher Farma Recent Development
6.4 Lundbeck
6.4.1 Lundbeck Corporation Information
6.4.2 Lundbeck Description, Business Overview and Total Revenue
6.4.3 Lundbeck Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Lundbeck Products Offered
6.4.5 Lundbeck Recent Development
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description, Business Overview and Total Revenue
6.5.3 Novartis Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis Products Offered
6.5.5 Novartis Recent Development
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description, Business Overview and Total Revenue
6.6.3 Perrigo Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Perrigo Products Offered
6.6.5 Perrigo Recent Development
6.7 Grindeks
6.6.1 Grindeks Corporation Information
6.6.2 Grindeks Description, Business Overview and Total Revenue
6.6.3 Grindeks Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Grindeks Products Offered
6.7.5 Grindeks Recent Development
6.8 Endo International
6.8.1 Endo International Corporation Information
6.8.2 Endo International Description, Business Overview and Total Revenue
6.8.3 Endo International Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Endo International Products Offered
6.8.5 Endo International Recent Development
6.9 Amneal Pharma
6.9.1 Amneal Pharma Corporation Information
6.9.2 Amneal Pharma Description, Business Overview and Total Revenue
6.9.3 Amneal Pharma Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Amneal Pharma Products Offered
6.9.5 Amneal Pharma Recent Development
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description, Business Overview and Total Revenue
6.10.3 Cipla Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Cipla Products Offered
6.10.5 Cipla Recent Development
6.11 Upsher-Smith
6.11.1 Upsher-Smith Corporation Information
6.11.2 Upsher-Smith Vigabatrin Description, Business Overview and Total Revenue
6.11.3 Upsher-Smith Vigabatrin Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Upsher-Smith Products Offered
6.11.5 Upsher-Smith Recent Development
7 VIGABATRIN MANUFACTURING COST ANALYSIS
7.1 Vigabatrin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vigabatrin
7.4 Vigabatrin Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Vigabatrin Distributors List
8.3 Vigabatrin Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Vigabatrin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vigabatrin by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vigabatrin by Type (2021-2026)
10.2 Vigabatrin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vigabatrin by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vigabatrin by Application (2021-2026)
10.3 Vigabatrin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vigabatrin by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vigabatrin by Region (2021-2026)
10.4 North America Vigabatrin Estimates and Projections (2021-2026)
10.5 Europe Vigabatrin Estimates and Projections (2021-2026)
10.6 Asia Pacific Vigabatrin Estimates and Projections (2021-2026)
10.7 Latin America Vigabatrin Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vigabatrin Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Vigabatrin Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vigabatrin Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Vigabatrin Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Vigabatrin Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Vigabatrin Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Vigabatrin Players to Combat Covid-19 Impact
Table 9. Global Key Vigabatrin Manufacturers Covered in This Study
Table 10. Global Vigabatrin Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Vigabatrin Sales Share by Manufacturers (2015-2020)
Table 12. Global Vigabatrin Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Vigabatrin Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Vigabatrin Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Vigabatrin Sales Sites and Area Served
Table 16. Manufacturers Vigabatrin Product Types
Table 17. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Vigabatrin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vigabatrin as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Vigabatrin Players
Table 21. Global Vigabatrin Sales (K Units) by Region (2015-2020)
Table 22. Global Vigabatrin Sales Market Share by Region (2015-2020)
Table 23. Global Vigabatrin Revenue (Million US$) by Region (2015-2020)
Table 24. Global Vigabatrin Revenue Market Share by Region (2015-2020)
Table 25. North America Vigabatrin Sales by Country (2015-2020) (K Units)
Table 26. North America Vigabatrin Sales Market Share by Country (2015-2020)
Table 27. North America Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Vigabatrin Revenue Market Share by Country (2015-2020)
Table 29. Europe Vigabatrin Sales by Country (2015-2020) (K Units)
Table 30. Europe Vigabatrin Sales Market Share by Country (2015-2020)
Table 31. Europe Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Vigabatrin Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Vigabatrin Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Vigabatrin Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Vigabatrin Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Vigabatrin Revenue Market Share by Region (2015-2020)
Table 37. Latin America Vigabatrin Sales by Country (2015-2020) (K Units)
Table 38. Latin America Vigabatrin Sales Market Share by Country (2015-2020)
Table 39. Latin America Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Vigabatrin Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Vigabatrin Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Vigabatrin Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Vigabatrin Revenue Market Share by Country (2015-2020)
Table 45. Global Vigabatrin Sales (K Units) by Type (2015-2020)
Table 46. Global Vigabatrin Sales Share by Type (2015-2020)
Table 47. Global Vigabatrin Revenue (Million US$) by Type (2015-2020)
Table 48. Global Vigabatrin Revenue Share by Type (2015-2020)
Table 49. Global Vigabatrin Price (US$/Unit) by Type (2015-2020)
Table 50. Global Vigabatrin Sales (K Units) by Application (2015-2020)
Table 51. Global Vigabatrin Sales Market Share by Application (2015-2020)
Table 52. Global Vigabatrin Sales Growth Rate by Application (2015-2020)
Table 53. Sanofi Vigabatrin Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Main Product
Table 57. Sanofi Recent Development
Table 58. Benta Pharma Industries Vigabatrin Corporation Information
Table 59. Benta Pharma Industries Corporation Information
Table 60. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Benta Pharma Industries Main Product
Table 62. Benta Pharma Industries Recent Development
Table 63. Dr. Fisher Farma Vigabatrin Corporation Information
Table 64. Dr. Fisher Farma Corporation Information
Table 65. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Dr. Fisher Farma Main Product
Table 67. Dr. Fisher Farma Recent Development
Table 68. Lundbeck Vigabatrin Corporation Information
Table 69. Lundbeck Corporation Information
Table 70. Lundbeck Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Lundbeck Main Product
Table 72. Lundbeck Recent Development
Table 73. Novartis Vigabatrin Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Perrigo Vigabatrin Corporation Information
Table 79. Perrigo Corporation Information
Table 80. Perrigo Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Perrigo Main Product
Table 82. Perrigo Recent Development
Table 83. Grindeks Vigabatrin Corporation Information
Table 84. Grindeks Corporation Information
Table 85. Grindeks Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Grindeks Main Product
Table 87. Grindeks Recent Development
Table 88. Endo International Vigabatrin Corporation Information
Table 89. Endo International Corporation Information
Table 90. Endo International Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Endo International Main Product
Table 92. Endo International Recent Development
Table 93. Amneal Pharma Vigabatrin Corporation Information
Table 94. Amneal Pharma Corporation Information
Table 95. Amneal Pharma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Amneal Pharma Main Product
Table 97. Amneal Pharma Recent Development
Table 98. Cipla Vigabatrin Corporation Information
Table 99. Cipla Corporation Information
Table 100. Cipla Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Cipla Main Product
Table 102. Cipla Recent Development
Table 103. Upsher-Smith Vigabatrin Corporation Information
Table 104. Upsher-Smith Corporation Information
Table 105. Upsher-Smith Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Upsher-Smith Main Product
Table 107. Upsher-Smith Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Vigabatrin Distributors List
Table 111. Vigabatrin Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Vigabatrin Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Vigabatrin Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Vigabatrin Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Vigabatrin Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Vigabatrin Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Vigabatrin Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Vigabatrin Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Vigabatrin Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Vigabatrin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Vigabatrin Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 1. Global Vigabatrin Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vigabatrin Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Vigabatrin Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Vigabatrin Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Vigabatrin Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Vigabatrin Players to Combat Covid-19 Impact
Table 9. Global Key Vigabatrin Manufacturers Covered in This Study
Table 10. Global Vigabatrin Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Vigabatrin Sales Share by Manufacturers (2015-2020)
Table 12. Global Vigabatrin Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Vigabatrin Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Vigabatrin Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Vigabatrin Sales Sites and Area Served
Table 16. Manufacturers Vigabatrin Product Types
Table 17. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Vigabatrin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vigabatrin as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Vigabatrin Players
Table 21. Global Vigabatrin Sales (K Units) by Region (2015-2020)
Table 22. Global Vigabatrin Sales Market Share by Region (2015-2020)
Table 23. Global Vigabatrin Revenue (Million US$) by Region (2015-2020)
Table 24. Global Vigabatrin Revenue Market Share by Region (2015-2020)
Table 25. North America Vigabatrin Sales by Country (2015-2020) (K Units)
Table 26. North America Vigabatrin Sales Market Share by Country (2015-2020)
Table 27. North America Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Vigabatrin Revenue Market Share by Country (2015-2020)
Table 29. Europe Vigabatrin Sales by Country (2015-2020) (K Units)
Table 30. Europe Vigabatrin Sales Market Share by Country (2015-2020)
Table 31. Europe Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Vigabatrin Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Vigabatrin Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Vigabatrin Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Vigabatrin Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Vigabatrin Revenue Market Share by Region (2015-2020)
Table 37. Latin America Vigabatrin Sales by Country (2015-2020) (K Units)
Table 38. Latin America Vigabatrin Sales Market Share by Country (2015-2020)
Table 39. Latin America Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Vigabatrin Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Vigabatrin Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Vigabatrin Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Vigabatrin Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Vigabatrin Revenue Market Share by Country (2015-2020)
Table 45. Global Vigabatrin Sales (K Units) by Type (2015-2020)
Table 46. Global Vigabatrin Sales Share by Type (2015-2020)
Table 47. Global Vigabatrin Revenue (Million US$) by Type (2015-2020)
Table 48. Global Vigabatrin Revenue Share by Type (2015-2020)
Table 49. Global Vigabatrin Price (US$/Unit) by Type (2015-2020)
Table 50. Global Vigabatrin Sales (K Units) by Application (2015-2020)
Table 51. Global Vigabatrin Sales Market Share by Application (2015-2020)
Table 52. Global Vigabatrin Sales Growth Rate by Application (2015-2020)
Table 53. Sanofi Vigabatrin Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Main Product
Table 57. Sanofi Recent Development
Table 58. Benta Pharma Industries Vigabatrin Corporation Information
Table 59. Benta Pharma Industries Corporation Information
Table 60. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Benta Pharma Industries Main Product
Table 62. Benta Pharma Industries Recent Development
Table 63. Dr. Fisher Farma Vigabatrin Corporation Information
Table 64. Dr. Fisher Farma Corporation Information
Table 65. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Dr. Fisher Farma Main Product
Table 67. Dr. Fisher Farma Recent Development
Table 68. Lundbeck Vigabatrin Corporation Information
Table 69. Lundbeck Corporation Information
Table 70. Lundbeck Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Lundbeck Main Product
Table 72. Lundbeck Recent Development
Table 73. Novartis Vigabatrin Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Perrigo Vigabatrin Corporation Information
Table 79. Perrigo Corporation Information
Table 80. Perrigo Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Perrigo Main Product
Table 82. Perrigo Recent Development
Table 83. Grindeks Vigabatrin Corporation Information
Table 84. Grindeks Corporation Information
Table 85. Grindeks Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Grindeks Main Product
Table 87. Grindeks Recent Development
Table 88. Endo International Vigabatrin Corporation Information
Table 89. Endo International Corporation Information
Table 90. Endo International Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Endo International Main Product
Table 92. Endo International Recent Development
Table 93. Amneal Pharma Vigabatrin Corporation Information
Table 94. Amneal Pharma Corporation Information
Table 95. Amneal Pharma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Amneal Pharma Main Product
Table 97. Amneal Pharma Recent Development
Table 98. Cipla Vigabatrin Corporation Information
Table 99. Cipla Corporation Information
Table 100. Cipla Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Cipla Main Product
Table 102. Cipla Recent Development
Table 103. Upsher-Smith Vigabatrin Corporation Information
Table 104. Upsher-Smith Corporation Information
Table 105. Upsher-Smith Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Upsher-Smith Main Product
Table 107. Upsher-Smith Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Vigabatrin Distributors List
Table 111. Vigabatrin Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Vigabatrin Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Vigabatrin Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Vigabatrin Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Vigabatrin Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Vigabatrin Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Vigabatrin Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Vigabatrin Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Vigabatrin Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Vigabatrin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Vigabatrin Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Vigabatrin
Figure 2. Global Vigabatrin Sales Market Share by Type: 2020 VS 2026
Figure 3. Tablet Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Vigabatrin Consumption Market Share by Application: 2020 VS 2026
Figure 6. Infantile Spasms (IS)
Figure 7. Partial-Onset Seizures
Figure 8. Refractory Complex Partial Seizures
Figure 9. Global Vigabatrin Market Size 2015-2026 (US$ Million)
Figure 10. Global Vigabatrin Sales Capacity (K Units) (2015-2026)
Figure 11. Global Vigabatrin Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Vigabatrin Sales Share by Manufacturers in 2020
Figure 13. Global Vigabatrin Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Vigabatrin Revenue in 2019
Figure 15. Vigabatrin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Vigabatrin Sales Market Share by Region (2015-2020)
Figure 17. Global Vigabatrin Sales Market Share by Region in 2019
Figure 18. Global Vigabatrin Revenue Market Share by Region (2015-2020)
Figure 19. Global Vigabatrin Revenue Market Share by Region in 2019
Figure 20. North America Vigabatrin Sales Market Share by Country in 2019
Figure 21. North America Vigabatrin Revenue Market Share by Country in 2019
Figure 22. U.S. Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Vigabatrin Sales Market Share by Country in 2019
Figure 27. Europe Vigabatrin Revenue Market Share by Country in 2019
Figure 28. Germany Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Vigabatrin Sales Market Share by Region in 2019
Figure 39. Asia Pacific Vigabatrin Revenue Market Share by Region in 2019
Figure 40. China Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Vigabatrin Sales Market Share by Country in 2019
Figure 63. Latin America Vigabatrin Revenue Market Share by Country in 2019
Figure 64. Mexico Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Vigabatrin Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Vigabatrin Revenue Market Share by Country in 2019
Figure 72. Turkey Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Vigabatrin by Type (2015-2020)
Figure 79. Sales Market Share of Vigabatrin by Type in 2019
Figure 80. Revenue Share of Vigabatrin by Type (2015-2020)
Figure 81. Revenue Market Share of Vigabatrin by Type in 2019
Figure 82. Global Vigabatrin Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Vigabatrin Sales Market Share by Application (2015-2020)
Figure 84. Global Vigabatrin Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Vigabatrin by Application (2015-2020)
Figure 86. Global Revenue Share of Vigabatrin by Application in 2020
Figure 87. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Benta Pharma Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Dr. Fisher Farma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Grindeks Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Amneal Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Upsher-Smith Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Vigabatrin
Figure 100. Manufacturing Process Analysis of Vigabatrin
Figure 101. Vigabatrin Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
Figure 1. Picture of Vigabatrin
Figure 2. Global Vigabatrin Sales Market Share by Type: 2020 VS 2026
Figure 3. Tablet Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Vigabatrin Consumption Market Share by Application: 2020 VS 2026
Figure 6. Infantile Spasms (IS)
Figure 7. Partial-Onset Seizures
Figure 8. Refractory Complex Partial Seizures
Figure 9. Global Vigabatrin Market Size 2015-2026 (US$ Million)
Figure 10. Global Vigabatrin Sales Capacity (K Units) (2015-2026)
Figure 11. Global Vigabatrin Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Vigabatrin Sales Share by Manufacturers in 2020
Figure 13. Global Vigabatrin Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Vigabatrin Revenue in 2019
Figure 15. Vigabatrin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Vigabatrin Sales Market Share by Region (2015-2020)
Figure 17. Global Vigabatrin Sales Market Share by Region in 2019
Figure 18. Global Vigabatrin Revenue Market Share by Region (2015-2020)
Figure 19. Global Vigabatrin Revenue Market Share by Region in 2019
Figure 20. North America Vigabatrin Sales Market Share by Country in 2019
Figure 21. North America Vigabatrin Revenue Market Share by Country in 2019
Figure 22. U.S. Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Vigabatrin Sales Market Share by Country in 2019
Figure 27. Europe Vigabatrin Revenue Market Share by Country in 2019
Figure 28. Germany Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Vigabatrin Sales Market Share by Region in 2019
Figure 39. Asia Pacific Vigabatrin Revenue Market Share by Region in 2019
Figure 40. China Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Vigabatrin Sales Market Share by Country in 2019
Figure 63. Latin America Vigabatrin Revenue Market Share by Country in 2019
Figure 64. Mexico Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Vigabatrin Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Vigabatrin Revenue Market Share by Country in 2019
Figure 72. Turkey Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Vigabatrin Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Vigabatrin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Vigabatrin by Type (2015-2020)
Figure 79. Sales Market Share of Vigabatrin by Type in 2019
Figure 80. Revenue Share of Vigabatrin by Type (2015-2020)
Figure 81. Revenue Market Share of Vigabatrin by Type in 2019
Figure 82. Global Vigabatrin Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Vigabatrin Sales Market Share by Application (2015-2020)
Figure 84. Global Vigabatrin Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Vigabatrin by Application (2015-2020)
Figure 86. Global Revenue Share of Vigabatrin by Application in 2020
Figure 87. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Benta Pharma Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Dr. Fisher Farma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Grindeks Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Amneal Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Upsher-Smith Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Vigabatrin
Figure 100. Manufacturing Process Analysis of Vigabatrin
Figure 101. Vigabatrin Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Vigabatrin Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Vigabatrin Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
